Trump Administration's Strategy to Alter Global Drug Pricing
Published on: Aug. 7, 2025, 8:39 p.m. | Source: Devdiscourse
The Trump administration is discussing with drugmakers ways to increase medicine prices in Europe and beyond to lower U.S. costs. The approach involves supporting international negotiations through a 'most favored nation' pricing model. This priority aims to address the high prescription drug costs in the U.S.
